Intervention Protocol

Probiotic agents for the treatment of diarrhoea-predominant irritable bowel syndrome

  1. Ping Wang2,
  2. Xudong Tang3,
  3. Taixiang Wu1,*,
  4. Geng Liu2

Editorial Group: Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group

Published Online: 19 APR 2006

DOI: 10.1002/14651858.CD005985


How to Cite

Wang P, Tang X, Wu T, Liu G. Probiotic agents for the treatment of diarrhoea-predominant irritable bowel syndrome (Protocol). Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD005985. DOI: 10.1002/14651858.CD005985.

Author Information

  1. 1

    West China Hospital, Sichuan University, Chinese Cochrane Centre, Chinese EBM Centre, Chengdu, Sichuan, China

  2. 2

    Guang AnMen Hospital, Gastroenterology Department, Beijing, China

  3. 3

    XiYuan Hospital Affiliated to China Academy of TCM, GI department, Beijing, HaiDian, China

*Taixiang Wu, Chinese Cochrane Centre, Chinese EBM Centre, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China. txwutx@hotmail.com. txwutx@public.cd.sc.cn.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 APR 2006

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective of this systematic review is to assess the efficacy and safety of probiotic agents for the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D).